|
Volumn 21, Issue 4 B, 2001, Pages 2895-2900
|
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
Chemoprevention; Curcumin; Pharmacokinetics; Phase I clinical trial
|
Indexed keywords
CURCUMIN;
ADULT;
AGED;
ARTICLE;
BLADDER CANCER;
BOWEN DISEASE;
CANCER PREVENTION;
CANCER RISK;
CARCINOGENESIS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG EXCRETION;
DRUG HALF LIFE;
DRUG MECHANISM;
FEMALE;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HIGH RISK POPULATION;
HISTOPATHOLOGY;
HUMAN;
INTESTINE METAPLASIA;
LEUKOPLAKIA;
MALE;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
TOXICITY;
TUMOR BIOPSY;
URINARY EXCRETION;
UTERINE CERVIX CARCINOMA IN SITU;
ADULT;
AGED;
ANTICARCINOGENIC AGENTS;
ARSENICALS;
BOWEN'S DISEASE;
CARCINOMA, TRANSITIONAL CELL;
CERVICAL INTRAEPITHELIAL NEOPLASIA;
CURCUMIN;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
LEUKOPLAKIA, ORAL;
MALE;
METAPLASIA;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
PRECANCEROUS CONDITIONS;
PROSPECTIVE STUDIES;
RISK;
SKIN NEOPLASMS;
STOMACH;
STOMACH NEOPLASMS;
TREATMENT OUTCOME;
URINARY BLADDER NEOPLASMS;
UTERINE CERVICAL NEOPLASMS;
|
EID: 0035174504
PISSN: 02507005
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1967)
|
References (28)
|